The invention concerns a compound of the formula (I); wherein Ring A is heterocyclyl; m is 0-4 and each R
1
is a group such as hydroxy, halo, trifluoromethyl and cyano; Ring B is ring such as thienyl, thiadiazolyl, thiazolyl, pyrimidyl, pyrazinyl, pyridazinyl and pyridyl; R
2
is halo and n is 0-2; and each R
4
is a group such as hydroxy, halo, trifluoromethyl and cyano; p is 0-4; and R
3
is amino or hydroxy; or pharmaceutically-acceptable salts or in-vivo-hydrolysable ester or amide thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by histone deacetylase.
本发明涉及式(I)的化合物;其中环A是杂环基;m为0-4,每个R1为羟基、卤素、三
氟甲基和
氰基等基团;环B是
噻吩基、
噻二唑基、
噻唑基、
嘧啶基、
吡嗪基、
吡啶并
嘧啶基和
吡啶基等环基;R2为卤素,n为0-2;每个R4为羟基、卤素、三
氟甲基和
氰基等基团;p为0-4;R3为
氨基或羟基;或其药学上可接受的盐或体内可
水解的酯或酰胺;其制备方法、含有它们的制药组合物以及它们在治疗组织脱乙酰化酶介导的疾病或医学状况中的应用。